| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |